School of Mathematics & Statistics

Miss Samantha Hinsley

  • Honorary Research Fellow (School of Mathematics & Statistics)

email: Samantha.Hinsley@glasgow.ac.uk

Institute of Cancer Sciences, Gartnavel Campus, Clinical Trials Unit

Import to contacts

ORCID iDhttps://orcid.org/0000-0001-6903-4688

Publications

List by: Type | Date

Jump to: 2023 | 2022 | 2021 | 2020
Number of items: 8.

2023

Crabb, S. J. et al. (2023) A randomized, double-blind, biomarker-selected, phase ii clinical trial of maintenance poly adp-ribose polymerase inhibition with rucaparib following chemotherapy for metastatic urothelial carcinoma. Journal of Clinical Oncology, 41(1), pp. 54-64. (doi: 10.1200/JCO.22.00405) (PMID:35960902) (PMCID:PMC9788980)

2022

Brown, Sarah R., Hinsley, Samantha ORCID logoORCID: https://orcid.org/0000-0001-6903-4688, Hall, Emma, Hurt, Chris, Baird, Richard D., Forster, Martin, Scarsbrook, Andrew F. and Adams, Richard A. (2022) A road map for designing phase I clinical trials of radiotherapy-novel agent combinations. Clinical Cancer Research, 28(17), pp. 3639-3651. (doi: 10.1158/1078-0432.CCR-21-4087) (PMID:35552622)

Homer, V. et al. (2022) Early phase clinical trials extension to guidelines for the content of statistical analysis plans. British Medical Journal, 376, e068177. (doi: 10.1136/bmj-2021-068177) (PMID:35131744) (PMCID:PMC8819597)

2021

Tsim, S. et al. (2021) Serum proteomics and plasma fibulin-3 in differentiation of mesothelioma from asbestos-exposed controls and patients with other pleural diseases. Journal of Thoracic Oncology, 16(10), pp. 1705-1717. (doi: 10.1016/j.jtho.2021.05.018) (PMID:34116230) (PMCID:PMC8514249)

Spiliopoulou, Pavlina ORCID logoORCID: https://orcid.org/0000-0002-6486-6319, Hinsley, Samantha ORCID logoORCID: https://orcid.org/0000-0001-6903-4688, Mcneish, Iain A. ORCID logoORCID: https://orcid.org/0000-0002-9387-7586, Roxburgh, Patricia ORCID logoORCID: https://orcid.org/0000-0001-9869-591X and Glasspool, Rosalind (2021) Metronomic oral cyclophosphamide in relapsed ovarian cancer. International Journal of Gynecological Cancer, 31, pp. 1037-1044. (doi: 10.1136/ijgc-2021-002467) (PMID:34016703)

2020

Hanna, C. R. et al. (2020) Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials, 21(935), (doi: 10.1186/s13063-020-04891-1) (PMID:33213530) (PMCID:PMC7675389)

Talhouk, A. et al. (2020) Development and validation of the gene-expression predictor of high-grade-serous ovarian carcinoma molecular subTYPE (PrOTYPE). Clinical Cancer Research, 26(20), (doi: 10.1158/1078-0432.CCR-20-0103) (PMID:32554541) (PMCID:PMC7572656)

Millstein, J. et al. (2020) Prognostic gene expression signature for high-grade serous ovarian cancer. Annals of Oncology, 31(9), pp. 1240-1250. (doi: 10.1016/j.annonc.2020.05.019) (PMID:32473302) (PMCID:PMC7484370)

This list was generated on Mon Sep 14 23:53:06 2026 BST.
Jump to: Articles
Number of items: 8.

Articles

Crabb, S. J. et al. (2023) A randomized, double-blind, biomarker-selected, phase ii clinical trial of maintenance poly adp-ribose polymerase inhibition with rucaparib following chemotherapy for metastatic urothelial carcinoma. Journal of Clinical Oncology, 41(1), pp. 54-64. (doi: 10.1200/JCO.22.00405) (PMID:35960902) (PMCID:PMC9788980)

Brown, Sarah R., Hinsley, Samantha ORCID logoORCID: https://orcid.org/0000-0001-6903-4688, Hall, Emma, Hurt, Chris, Baird, Richard D., Forster, Martin, Scarsbrook, Andrew F. and Adams, Richard A. (2022) A road map for designing phase I clinical trials of radiotherapy-novel agent combinations. Clinical Cancer Research, 28(17), pp. 3639-3651. (doi: 10.1158/1078-0432.CCR-21-4087) (PMID:35552622)

Homer, V. et al. (2022) Early phase clinical trials extension to guidelines for the content of statistical analysis plans. British Medical Journal, 376, e068177. (doi: 10.1136/bmj-2021-068177) (PMID:35131744) (PMCID:PMC8819597)

Tsim, S. et al. (2021) Serum proteomics and plasma fibulin-3 in differentiation of mesothelioma from asbestos-exposed controls and patients with other pleural diseases. Journal of Thoracic Oncology, 16(10), pp. 1705-1717. (doi: 10.1016/j.jtho.2021.05.018) (PMID:34116230) (PMCID:PMC8514249)

Spiliopoulou, Pavlina ORCID logoORCID: https://orcid.org/0000-0002-6486-6319, Hinsley, Samantha ORCID logoORCID: https://orcid.org/0000-0001-6903-4688, Mcneish, Iain A. ORCID logoORCID: https://orcid.org/0000-0002-9387-7586, Roxburgh, Patricia ORCID logoORCID: https://orcid.org/0000-0001-9869-591X and Glasspool, Rosalind (2021) Metronomic oral cyclophosphamide in relapsed ovarian cancer. International Journal of Gynecological Cancer, 31, pp. 1037-1044. (doi: 10.1136/ijgc-2021-002467) (PMID:34016703)

Hanna, C. R. et al. (2020) Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials, 21(935), (doi: 10.1186/s13063-020-04891-1) (PMID:33213530) (PMCID:PMC7675389)

Talhouk, A. et al. (2020) Development and validation of the gene-expression predictor of high-grade-serous ovarian carcinoma molecular subTYPE (PrOTYPE). Clinical Cancer Research, 26(20), (doi: 10.1158/1078-0432.CCR-20-0103) (PMID:32554541) (PMCID:PMC7572656)

Millstein, J. et al. (2020) Prognostic gene expression signature for high-grade serous ovarian cancer. Annals of Oncology, 31(9), pp. 1240-1250. (doi: 10.1016/j.annonc.2020.05.019) (PMID:32473302) (PMCID:PMC7484370)

This list was generated on Mon Sep 14 23:53:06 2026 BST.